Retraction notice to “Linking Plasma Cortisol Levels to Phenotypic Heterogeneity of Posttraumatic Stress Symptomatology” [PNEC 39C (2014) 88–93] (Psychoneuroendocrinology (2014) 39 (88–93), (S0306453013003673), (10.1016/j.psyneuen.2013.10.003));Linking plasma cortisol levels to phenotypic heterogeneity of posttraumatic stress symptomatology

Psychoneuroendocrinology

Volumn 39, Issue 1, 2014, Pages 88-93

  Horn, Charlotte A C ^a   Pietrzak, Robert H ^b,c   Corsi Travali, Stefani ^a   Neumeister, Alexander ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

5 Factor PTSD model; Cortisol; Hypothalamic adrenal pituitary axis; Numbing; PTSD

Indexed keywords

HYDROCORTISONE;

5 FACTOR DYSPHORIC AROUSAL MODEL; ADULT; AGE; ALCOHOL USE DISORDER; ANXIETY DISORDER; ARTICLE; CAUCASIAN; CLINICAL ARTICLE; CLINICIAN ADMINISTERED PTSD SCALE; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; EDUCATIONAL STATUS; EMOTIONAL ATTACHMENT; EMOTIONAL NUMBING SYMPTOM; FEMALE; HAMILTON ANXIETY SCALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; PSYCHOLOGICAL RATING SCALE; SCORING SYSTEM; SMOKING HABIT; ALCOHOL CONSUMPTION; EMOTIONALITY; ETHNICITY; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MOOD DISORDER; PANIC; PHENOTYPE; SMOKING;

5-FACTOR PTSD MODEL; CORTISOL; HYPOTHALAMIC-ADRENAL-PITUITARY AXIS; NUMBING; PTSD;

ADULT; AROUSAL; DEPRESSION; FEMALE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MIDDLE AGED; PHENOTYPE; PITUITARY-ADRENAL SYSTEM; SEVERITY OF ILLNESS INDEX; STRESS DISORDERS, POST-TRAUMATIC;

EID: 84888069569     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2020.104763     Document Type: Erratum

References (26)

1. Armour C., Carragher N., et al. Assessing the fit of the dysphoric arousal model across two nationally representative epidemiological surveys: The Australian NSMHWB and the United States NESARC. J. Anxiety Disord. 2013, 27(1):109-115.
2. Blake D.D., Weathers F.W., et al. The development of a Clinician-Administered PTSD Scale. J. Trauma. Stress 1995, 8(1):75-90.
3. Daskalakis N.P., Lehrner A., et al. Endocrine aspects of post-traumatic stress disorder and implications for diagnosis and treatment. Endocrinol. Metab. Clin. N. Am. 2013, 42(3):503-513.
4. Elhai J.D., Biehn T.L., et al. Evidence for a unique PTSD construct represented by PTSD's D1-D3 symptoms. J. Anxiety Disord. 2011, 25(3):340-345.
5. First M.B., Spitzer R.L., et al. Structured Clinical Interview for DSM-IV Axis I Disorders 1995, New York State Psychiatric Institute, Biometrics Research, New York.
6. Hamilton M. The assessment of anxiety states by rating. Br. J. Med. Psychol. 1959, 32:50-55.
7. Kubany E.S., Haynes S.N., et al. Development and preliminary validation of a brief broad-spectrum measure of trauma exposure: the Traumatic Life Events Questionnaire. Psychol. Assess. 2000, 12(2):210-224.
8. Larsson C.A., Gullberg B., et al. Salivary cortisol differs with age and sex and shows inverse associations with WHR in Swedish women: a cross-sectional study. BMC Endocr. Disord. 2009, 9:16.
9. Mason J.W., Wang S., et al. Psychogenic lowering of urinary cortisol levels linked to increased emotional numbing and a shame-depressive syndrome in combat-related posttraumatic stress disorder. Psychosom. Med. 2001, 63(3):387-401.
10. Montgomery S.A., Asberg M. A new depression scale designed to be sensitive to change. Br. J. Psychiatry 1979, 134:382-389.
11. Morris M.C., Compas B.E., et al. Relations among posttraumatic stress disorder, comorbid major depression, and HPA function: a systematic review and meta-analysis. Clin. Psychol. Rev. 2012, 32(4):301-315.
12. Neumeister A., Normandin M.D., et al. Elevated brain cannabinoid CB1 receptor availability in posttraumatic stress disorder: a positron emission tomography study. Mol. Psychiatry 2013, 18(9):1034-1040. [Epub 2013 May 14]. 10.1038/mp.2013.61.
13. Pietrzak R.H., Gallezot J.-D., et al. Association of posttraumatic stress disorder with reduced in vivo norepinephrine transporter availability in the locus coeruleus. JAMA Psychiatry 2013, (Published online September 18, 2013). 10.1001/jamapsychiatry.2013.399.
14. Pietrzak R.H., Henry S., et al. Linking in vivo brain serotonin type 1B receptor density to phenotypic heterogeneity of posttraumatic stress symptomatology. Mol. Psychiatry 2013, 18(4):399-401.
15. Pietrzak R.H., Tsai J., et al. Support for a novel five-factor model of posttraumatic stress symptoms in three independent samples of Iraq/Afghanistan veterans: a confirmatory factor analytic study. J. Psychiatr. Res. 2012, 46(3):317-322.
16. Steudte S., Kirschbaum C., et al. Hair cortisol as a biomarker of traumatization in healthy individuals and posttraumatic stress disorder patients. Biol. Psychiatry. 2013, 74(9 (Nov)):639-646. [Epub 2013 Apr 23]. http://www.ncbi.nlm.nih.gov/pubmed/23623187, 10.1016/j.biopsych.2013.03.011.
17. Wahbeh H., Oken B.S. Salivary cortisol lower in posttraumatic stress disorder. J. Trauma. Stress 2013, 26(2):241-248.
18. Watson D. Rethinking the mood and anxiety disorders: a quantitative hierarchical model for DSM-V. J. Abnorm. Psychol. 2005, 114(4):522-536.
19. Wessa M., Rohleder N., et al. Altered cortisol awakening response in posttraumatic stress disorder. Psychoneuroendocrinology 2006, 31(2):209-215.
20. Yehuda R. Status of glucocorticoid alterations in post-traumatic stress disorder. Ann. N. Y. Acad. Sci. 2009, 1179:56-69.
21. Yehuda R., Boisoneau D., et al. Dose-response changes in plasma cortisol and lymphocyte glucocorticoid receptors following dexamethasone administration in combat veterans with and without posttraumatic stress disorder. Arch. Gen. Psychiatry 1995, 52(7):583-593.
22. Yehuda R., Flory J.D., et al. Putative biological mechanisms for the association between early life adversity and the subsequent development of PTSD. Psychopharmacology (Berl.) 2010, 212(3):405-417.
23. Yehuda R., Golier J.A., et al. Enhanced sensitivity to glucocorticoids in peripheral mononuclear leukocytes in posttraumatic stress disorder. Biol. Psychiatry 2004, 55(11):1110-1116.
24. Yehuda R., Kahana B., et al. Low urinary cortisol excretion in Holocaust survivors with posttraumatic stress disorder. Am. J. Psychiatry 1995, 152(7):982-986.
25. Yehuda R., Southwick S.M., et al. Enhanced suppression of cortisol following dexamethasone administration in posttraumatic stress disorder. Am. J. Psychiatry 1993, 150(1):83-86.
26. Yufik T., Simms L.J. A meta-analytic investigation of the structure of posttraumatic stress disorder symptoms. J. Abnorm. Psychol. 2010, 119(4):764-776.